Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
08:05am, Tuesday, 06'th Feb 2024
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
08:00am, Monday, 05'th Feb 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Corporation (TWST) Q1 2024 Earnings Call Transcript
01:11pm, Friday, 02'nd Feb 2024
Twist Bioscience Corporation (TWST) Q1 2024 Earnings Call Transcript
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
07:30am, Friday, 02'nd Feb 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Expands Express Genes Rapid Synthesis Service
08:00am, Wednesday, 24'th Jan 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
08:00am, Tuesday, 16'th Jan 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
08:00am, Monday, 08'th Jan 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling cu
3 Genomics Stocks to Unlock the Future of Medicine
12:44pm, Tuesday, 19'th Dec 2023
Genomics is undeniably medicine's future, and genomics stocks stand to be the next big thing in healthcare as the industry matures. But the crux of the matter is when the industry will mature.
Twist Bioscience (TWST) Soars 12.5%: Is Further Upside Left in the Stock?
09:46am, Friday, 15'th Dec 2023
Twist Bioscience (TWST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term
5 Best Performing Stocks of the Top ETF of November
12:53pm, Friday, 01'st Dec 2023
ARK Innovation ETF (ARKK), which provides thematic multi-cap exposure to innovation across sectors, has gained 35.2%, becoming the best-performing ETF of November.
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
09:46am, Friday, 17'th Nov 2023
Twist Bioscience (TWST) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.94. This compares to loss of $0.91 per share a year ago.
A New Look At Twist Bioscience
04:55pm, Thursday, 02'nd Nov 2023
Today, we take a look synthetic biology company Twist Bioscience Corporation for the first time since spring. The company recently signed collaboration deals with two new drugmakers and saw upward ana
Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand
10:32am, Thursday, 24'th Aug 2023
Twist continues to expand its SynBio and NGS businesses, but its Biopharma business has had execution issues. Twist is focused on reducing costs, but it is still probably at least several years from G
Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential
01:39pm, Friday, 11'th Aug 2023
DNA is as fundamental to biotechnology as it is to biology itself. From synthetic biology to pharmaceuticals, making and using DNA is usually a necessary first step in bringing a biotech product to ma
Twist Bioscience Corporation (TWST) Q3 2023 Earnings Call Transcript
06:24pm, Friday, 04'th Aug 2023
Twist Bioscience Corporation (NASDAQ:TWST ) Q3 2023 Results Conference Call August 4, 2023 8:00 AM ET Company Participants Angela Bitting - SVP, Corporate Affairs and EGS Officer Dr. Emily Leproust -
